Christine L Bokman1, Jun Tashiro1, Eduardo A Perez1, David S Lasko2, Juan E Sola3. 1. Division of Pediatric Surgery, DeWitt-Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA. 2. South Florida Pediatric Surgeons P.A., Plantation, FL, USA. 3. Division of Pediatric Surgery, DeWitt-Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of Miami, Miami, FL, USA. Electronic address: jsola@med.miami.edu.
Abstract
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) remains a vital therapy for children requiring cardiopulmonary support. METHODS: The Kids' Inpatient Database (KID) was analyzed for ECMO (ICD-9-CM 39.65) patients between 1997 and 2009. RESULTS: Overall, 8005 cases were identified, consisting of neonatal (ECMO <30days of life; 33%), infant (30days to 1year; 46%), young child (1year to 5years; 9.7%), and older child (>5years; 11%) groups. Patients were most commonly male (56%), Caucasian (49%), and insured by Medicaid (46%). ECMO was indicated for respiratory distress syndrome (RDS; 33%), cardiac and circulatory congenital anomalies (CCCA; 22%), congenital diaphragmatic hernia (CDH; 13%), and persistent pulmonary hypertension of the newborn (PPHN; 10%). On multivariate analysis, length of stay (LOS) decreased over the study period, while total charges (TC) increased over time, p<0.001. Survival was higher for boys and those treated in large or urban teaching hospitals, p<0.05. ECMO for CDH, CCCA, and RDS had the highest associated mortality, p<0.001. Neonatal and infant ECMO had no difference in mortality vs. older children. CONCLUSIONS: While LOS for ECMO has decreased over time, TC has increased steadily. Improved survival is found in boys and patients at large or urban teaching hospitals. CDH, CCCA, and RDS portend poor survival outcomes as indicators for ECMO.
BACKGROUND: Extracorporeal membrane oxygenation (ECMO) remains a vital therapy for children requiring cardiopulmonary support. METHODS: The Kids' Inpatient Database (KID) was analyzed for ECMO (ICD-9-CM 39.65) patients between 1997 and 2009. RESULTS: Overall, 8005 cases were identified, consisting of neonatal (ECMO <30days of life; 33%), infant (30days to 1year; 46%), young child (1year to 5years; 9.7%), and older child (>5years; 11%) groups. Patients were most commonly male (56%), Caucasian (49%), and insured by Medicaid (46%). ECMO was indicated for respiratory distress syndrome (RDS; 33%), cardiac and circulatory congenital anomalies (CCCA; 22%), congenital diaphragmatic hernia (CDH; 13%), and persistent pulmonary hypertension of the newborn (PPHN; 10%). On multivariate analysis, length of stay (LOS) decreased over the study period, while total charges (TC) increased over time, p<0.001. Survival was higher for boys and those treated in large or urban teaching hospitals, p<0.05. ECMO for CDH, CCCA, and RDS had the highest associated mortality, p<0.001. Neonatal and infant ECMO had no difference in mortality vs. older children. CONCLUSIONS: While LOS for ECMO has decreased over time, TC has increased steadily. Improved survival is found in boys and patients at large or urban teaching hospitals. CDH, CCCA, and RDS portend poor survival outcomes as indicators for ECMO.
Authors: Sarah B Cairo; Mary Arbuthnot; Laura A Boomer; Michael W Dingeldein; Alexander Feliz; Samir Gadepalli; Chris R Newton; Robert Ricca; Adam M Vogel; David H Rothstein Journal: Pediatr Surg Int Date: 2018-08-21 Impact factor: 1.827
Authors: Sarah B Cairo; Mary Arbuthnot; Laura Boomer; Michael W Dingeldein; Alexander Feliz; Samir Gadepalli; Christopher R Newton; Pramod Puligandla; Robert Ricca; Peter Rycus; Adam M Vogel; Guan Yu; Ziqiang Chen; David H Rothstein Journal: Pediatr Crit Care Med Date: 2018-10 Impact factor: 3.624
Authors: Oliver Karam; Pierre Demaret; Alain Duhamel; Alison Shefler; Philip C Spinella; Simon J Stanworth; Marisa Tucci; Stéphane Leteurtre Journal: Ann Intensive Care Date: 2016-10-06 Impact factor: 6.925